BACKGROUND: and purpose: In this study, we employed a multiple microinfarction (MMI) based vascular dementia (VaD) model in aged rats and tested the therapeutic effects of Sildenafil, a phosphodiesterase type 5 inhibitor, on cognitive decline, white matter damage, autophagy and inflammatory response associated with VaD. METHODS: Male, aged (16-18 months) Wistar rats were subjected to MMI (800 ± 100, 70-100 μm cholesterol crystals injected into the internal carotid artery) and treated with or without Sildenafil (2 mg/kg, i.p) starting at 24 h after MMI daily for 28 days. Four experimental groups were employed: Sham control, Sham + Sildenafil, MMI, and MMI + Sildenafil. A battery of cognitive tests were performed and rats were sacrificed at 2...
AIM: This study aims to elucidate the possible ameliorative effect of silymarin on scopolamine-induc...
We investigated cognitive function, axonal/white matter (WM) changes and glymphatic function of vasc...
Contains fulltext : 200272.pdf (publisher's version ) (Open Access)BACKGROUND: Thi...
Background and Purpose: Vascular Dementia (VaD) caused by silent or mini strokes, affects cognition ...
BACKGROUND AND PURPOSE: Diabetes mellitus (DM) is a common metabolic disease among the middle-aged a...
BACKGROUND AND PURPOSE: Diabetes mellitus (DM) is a common metabolic disease among the middle-aged a...
BACKGROUND AND PURPOSE: Diabetes mellitus (DM) is a common metabolic disease among the middle-aged a...
Alzheimer’s disease (AD) is a progressive, neurological and psychiatric age associated disorder. Age...
Introduction: There are contradictory results about the effects of exercise and sildenafil on cognit...
Several studies point to an important function of cyclooxygenase (COX) and prostaglandin signaling i...
AbstractIn this study, we tested whether the phosphodiesterase-5 inhibitor sildenafil protects again...
Sildenafil citrate has shown to display beneficial cardiovascular effects, suggesting that it may ha...
Abstract BACKGROUND AND PURPOSE: Inhibitors of phosphodiesterase 5 (PDE5) affect signalling path...
2019-01-03Introduction: Alzheimer's disease (AD) is an insidious neurodegenerative disease that init...
INTRODUCTION: Phosphodiesterase (PDE) inhibitors improve signaling pathways in brain circuits by inc...
AIM: This study aims to elucidate the possible ameliorative effect of silymarin on scopolamine-induc...
We investigated cognitive function, axonal/white matter (WM) changes and glymphatic function of vasc...
Contains fulltext : 200272.pdf (publisher's version ) (Open Access)BACKGROUND: Thi...
Background and Purpose: Vascular Dementia (VaD) caused by silent or mini strokes, affects cognition ...
BACKGROUND AND PURPOSE: Diabetes mellitus (DM) is a common metabolic disease among the middle-aged a...
BACKGROUND AND PURPOSE: Diabetes mellitus (DM) is a common metabolic disease among the middle-aged a...
BACKGROUND AND PURPOSE: Diabetes mellitus (DM) is a common metabolic disease among the middle-aged a...
Alzheimer’s disease (AD) is a progressive, neurological and psychiatric age associated disorder. Age...
Introduction: There are contradictory results about the effects of exercise and sildenafil on cognit...
Several studies point to an important function of cyclooxygenase (COX) and prostaglandin signaling i...
AbstractIn this study, we tested whether the phosphodiesterase-5 inhibitor sildenafil protects again...
Sildenafil citrate has shown to display beneficial cardiovascular effects, suggesting that it may ha...
Abstract BACKGROUND AND PURPOSE: Inhibitors of phosphodiesterase 5 (PDE5) affect signalling path...
2019-01-03Introduction: Alzheimer's disease (AD) is an insidious neurodegenerative disease that init...
INTRODUCTION: Phosphodiesterase (PDE) inhibitors improve signaling pathways in brain circuits by inc...
AIM: This study aims to elucidate the possible ameliorative effect of silymarin on scopolamine-induc...
We investigated cognitive function, axonal/white matter (WM) changes and glymphatic function of vasc...
Contains fulltext : 200272.pdf (publisher's version ) (Open Access)BACKGROUND: Thi...